Elizabeth Cooper
Overview
Explore the profile of Elizabeth Cooper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
399
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Porter C, Beckett C, Cooper E, White L, Wallace D, Jakubski S, et al.
Lancet Reg Health Am
. 2024 Nov;
39:100909.
PMID: 39507365
Background: Long-term SARS-CoV-2 adverse health outcomes are of significant concern, especially among young adults with the potential for the greatest long-term morbidity. We sought to assess and characterize these outcomes...
3.
Wozniak T, Cooper E, Murphy M, Nguyen A, Conlan D, Smallbon V, et al.
Stud Health Technol Inform
. 2024 Sep;
318:42-47.
PMID: 39320179
The HOTspots digital surveillance platform (HOTspots) is a critical technology of the HOTspots Surveillance and Response Program. It provides timely point-of-care access to pathology and demographic data from previously underserved...
4.
Bonetti A, Tugnoli B, Ghiselli F, Markley G, Cooper E, Piva A, et al.
J Anim Sci
. 2024 Sep;
102.
PMID: 39289925
This study examined the action of a blend of botanicals (BOT) against lipopolysaccharide (LPS)-induced inflammation on cultured hepatocytes and weaning piglets. In vitro studies examined HepG2 cells treated with BOT...
5.
Brooks S, Sidhu K, Cooper E, Michelle Driedger S, Gisenya L, Kaur G, et al.
Vaccine
. 2024 Mar;
42(11):2793-2800.
PMID: 38514354
Objectives: Research on immigrant and refugee vaccination uptake in Canada shows that immunization decisions vary by vaccine type, location, age and migration status. Despite their diversity, these studies often treat...
6.
Cooper E, Oyagawa C, Johnson R, Choi P, Foliaki J, Correia J, et al.
Cell Commun Signal
. 2024 Jan;
22(1):30.
PMID: 38212807
Glioblastoma is the most common and aggressive primary brain tumour in adults. The development of anti-brain cancer agents are challenged by the blood-brain barrier and the resistance conferred by the...
7.
Gastol D, Marshall J, Cooper E, Mitchell C, Burnett D, Song T, et al.
Glob Chall
. 2022 Dec;
6(12):2200046.
PMID: 36532243
As electric vehicles become more widely used, there is a higher demand for lithium-ion batteries (LIBs) and hence a greater incentive to find better ways to recycle these at their...
8.
Cooper E, Woolf Z, Swanson M, Correia J, Schweder P, Mee E, et al.
Neurooncol Adv
. 2022 Nov;
4(1):vdac166.
PMID: 36382105
Background: Glioblastoma (GBM) is the most common and aggressive primary brain tumor in adults. Whilst the role of the efflux transporters are well established in GBM, the expression and function...
9.
Vangeti S, Periasamy S, Sun P, Balinsky C, Mahajan A, Kuzmina N, et al.
Microbiol Spectr
. 2022 Nov;
10(6):e0183722.
PMID: 36374040
We investigated the temporal profile of multiple components of the serological response after asymptomatic or mildly symptomatic SARS-CoV-2 infection, in a cohort of 67 previously SARS-CoV-2 naive young adults, up...
10.
Cooper E, Choi P, Hwang K, Nam K, Kim C, Shaban T, et al.
Chem Biol Drug Des
. 2022 Nov;
101(3):696-716.
PMID: 36323652
The development of chemotherapies for glioblastoma is hindered by their limited bioavailability and toxicity on normal brain function. To overcome these limitations, we investigated the structure-dependent activity of heptamethine cyanine...